DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

Woei-Jer Chuang (Inventor)

Research output: Patent

Abstract

The invention provides disintegrin variants, and more specifically to disintegrin variants which are selective .alpha.v.beta.3 integrin antagonists for treatment and prevention of .alpha.v.beta.3 integrin-associated diseases. The present invention also relates to pegylated proteins, including proteins comprising a disintegrin variant having an RGD motif variant .sup.48ARLDDL.sup.53. The invention also relates to the use of the polypeptides of the invention for the treatment and prevention of .alpha.v.beta.3 integrin-associated diseases.
Translated title of the contribution去整合蛋白變異體及其醫藥用途
Original languageEnglish
Patent number8183201
Publication statusPublished - 1800

Fingerprint Dive into the research topics of 'DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF'. Together they form a unique fingerprint.

Cite this